Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Osteogenesis imperfecta (OI), often referred to as "brittle bone disease," is a rare genetic disorder characterized by bones that break easily due to a deficiency or structural defect in type I collagen. While the primary impact is on skeletal health, Osteogenesis imperfecta can also affect connective tissues in the eyes, ears, skin, and teeth. What is Osteogenesis Imperfecta and how does it affect the body? Osteogenesis imperfecta is a heterogeneous group of genetic disorders that primarily affects the structural integrity of the skeletal system.
TL;DR: Osteogenesis imperfecta (OI), often referred to as "brittle bone disease," is a rare genetic disorder characterized by bones that break easily due to a deficiency or structural defect in type I collagen. While the primary impact is on skeletal health, Osteogenesis imperfecta can also affect connective tissues in the eyes, ears, skin, and teeth.
Osteogenesis imperfecta is a heterogeneous group of genetic disorders that primarily affects the structural integrity of the skeletal system. Because type I collagen is a vital building block for the entire body, people living with Osteogenesis imperfecta may experience a wide range of systemic manifestations beyond bone fragility. These can include blue-tinted sclera (the whites of the eyes), hearing loss, brittle teeth (dentinogenesis imperfecta), and hypermobile joints. Currently, 429 members of the DiseaseMaps.org community have shared their experiences living with this condition, highlighting the diverse ways it impacts daily life.
The severity of Osteogenesis imperfecta varies significantly between individuals. Medical professionals typically classify the condition into several types based on clinical symptoms and genetic markers:
Osteogenesis imperfecta is considered a rare disease, with an estimated prevalence of approximately 1 in 10,000 to 20,000 individuals worldwide. It affects males and females equally and occurs across all geographic locations and ethnic groups. Symptoms are usually present from birth, though the timing of diagnosis can vary depending on the severity of the clinical presentation. While most cases are inherited, a significant portion of Osteogenesis imperfecta cases arise from de novo (spontaneous) genetic mutations where there is no family history of the disease.
At its core, Osteogenesis imperfecta is caused by mutations in the COL1A1 or COL1A2 genes, which provide instructions for creating the proteins that form type I collagen. In healthy individuals, these proteins assemble into strong, flexible fibers. In individuals with Osteogenesis imperfecta, the body either produces too little collagen or produces collagen that is structurally abnormal. This molecular defect renders the bone matrix weak, making it highly susceptible to fractures from minimal trauma.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always consult with your physician regarding your specific health needs.